At RXIV Infusions, the focus is on helping you recharge, refocus, and improve your overall wellness
These may include discomfort, redness, or irritation at the injection site, mild bruising, headache, nausea or temporary digestive discomfort, and light-headedness shortly after administration
Originally developed as an anti-obesity drug candidate in the late 1990s, it has since found research applications in both metabolic studies and cartilage repair investigations
For Convenience-First Users: Capsules Capsule-based BPC157 may appeal to: Supplement users who prefer no needles Individuals experimenting with daily low-dose use Those who understand the trade-off in efficacy However, the majority of capsule products lack the dosing consistency and purity required for therapeutic benefit